Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
granisetron hydrochloride, Quantity: 3.36 mg (Equivalent: granisetron, Qty 3 mg)
Arrotex Pharmaceuticals Pty Ltd
granisetron hydrochloride
Injection
Excipient Ingredients: citric acid monohydrate; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections
Intravenous
5
(S4) Prescription Only Medicine
Adults: Granisetron Injection is indicated for use in adults for:,The prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy;,The prevention of nausea and vomiting induced by radiotherapy.,Granisetron Injection is also indicated for use in the prevention and treatment of post-operative nausea and vomiting.,Children: Granisetron injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.
Visual Identification: Granisetron Hydrochloride Injection, 3mg/3mL is a clear and colorless solution, in a type 1 glass ampoule; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2014-12-17